NFKB1 and dengue disease: Notably, drugs sharing the mechanism of actions in the “NF-kB pathway inhibitor”, “ATPase inhibitor”, “Adrenergic receptor antagonist” and “Serotonin receptor antagonist” seem to be promising candidates in Dengue treatment, and some previous pin-point functional tests have contributed evidence supporting the antiviral action of some of these mechanisms.